Skip to main content
Premium Trial:

Request an Annual Quote

AccessDx Acquires 2bPrecise From Allscripts

NEW YORK – AccessDx Holdings said Wednesday that it has acquired 2bPrecise, a service and technology provider that integrates genetic and genomic test results into electronic health records, from EHR giant Allscripts Healthcare Solutions for an undisclosed amount.

AccessDx, a Houston-based CAP/CLIA diagnostic laboratory and software firm, said that 2bPrecise will augment its line of molecular diagnostics, software, and services products, which already includes clinical decision support software brand MedTek21.

"We're thrilled to welcome the 2bPrecise team and platform as we execute on our combined vision for democratizing the use, interpretation, and delivery of advanced diagnostic solutions at the point of care," Joe Spinelli, senior VP of product and strategy for AccessDx, said in a statement. "Combined, our worldwide organization will be able to accelerate the pace of innovation and best serve the needs of healthcare organizations that continue to expand their adoption of actionable precision medicine solutions."

Assaf Halevy, founder and CEO of 2bPrecise, said that the combination will speed up adoption of precision medicine within healthcare organizations. "AccessDx is a genuine leader in genomic information management. Our collective capabilities will serve as a force … for the practical utilization of precision medicine," he said.

Israel-based 2bPrecise was founded in 2015 with Allscripts as its primary investor. The EHR vendor eventually purchased the startup in its entirety.

2bPrecise integrates genetic and genomic data from molecular labs with clinical information from EHRs into a clinical-genomic ontology for use by physicians. It has a relationship with EHR integration specialist Jase Health, a company that AccessDx forged a partnership with earlier this year.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.